Longevity Healthcare Market Exceeds $250 Billion, TD Cowen Says

TD Cowen analysts estimate that the total addressable market (TAM) for longevity healthcare exceeds $250 billion, according to a report from Barrons.com. This growing market, focused on extending healthy lifespan, creates opportunities for major healthcare companies such as Abbott Laboratories (ABT) and CVS Health (CVS).

Market Details

The longevity market includes products and services aimed at slowing aging and improving quality of life in advanced years. Analysts expect rising demand from aging populations to drive growth in sectors like diagnostics, medical devices, and pharmaceuticals.

Benefiting Companies

• Abbott Laboratories (ABT): Has a broad portfolio of diagnostic and health monitoring devices that support management of chronic diseases associated with aging.
• CVS Health (CVS): Benefits from its pharmacy network and primary care services through MinuteClinics and chronic disease management programs.

Context

The estimate comes as the global population aged 65 and over grows rapidly, increasing demand for long-term healthcare solutions. Neither ABT nor CVS has commented officially.

What This Means for Investors

The longevity market represents a long-term investment opportunity in healthcare, but investors should consider regulatory risks and competition. Monitoring market developments and quarterly reports is advised.